Adjuvant treatment in stage III gastric cancer patients in Brazil and Peru: Results of a retrospective study in two cancer centers in Latin America.
Jose Eduardo Nuñez(AC Camargo Hospital), Celso Abdon Lopes de Mello(AC Camargo Hospital), Rossana Mendoza(AC Camargo Hospital), Daniel Enríquez(Universidad Privada San Juan Bautista), Paola Montenegro(Instituto Nacional de Enfermedades Neoplásicas), Ana Caroline Fonseca Alves(AC Camargo Hospital), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Wilson Luiz da Costa(AC Camargo Hospital), Felipe José Fernández Coimbra(AC Camargo Hospital), Luis Taxa(Instituto Nacional de Enfermedades Neoplásicas), Tiago Cordeiro Felismino(AC Camargo Hospital), Maria D. Begnami(Hospital de Câncer de Barretos), R.C. Fogaroli(AC Camargo Hospital)
Cited by 0
Related Papers
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
|Journal of Clinical Oncology|2011|256
Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 Cases
|Brain Pathology|2008|178
Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations
|Acta Neuropathologica|2018|143
Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group
|Annals of Surgical Oncology|2016|132
EBV-associated Cutaneous NK/T-cell Lymphoma
|The American Journal of Surgical Pathology|2010|112